1-1 of 1
Harald Maier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Durable efficacy and long-term safety with pelabresib plus ruxolitinib in JAK Inhibitor–Naive myelofibrosis: 96-week Results from the Phase III MANIFEST-2 study

Free
Raajit Rampal, John Mascarenhas, Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron Gerds, Francesca Palandri, Vikas Gupta, Sung-Eun Lee, Alessandro Lucchesi, Andrew Kuykendall, Stephen Oh, Andrea Patriarca, alberto Alvarez-Larran, David Lavie, Moshe Talpaz, Jean-Jacques Kiladjian, Ruben Mesa, Monika Wroclawska, Xuechan Li, Thomas Lehmann, Harald Maier, Claire Harrison, Alessandro Vannucchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 910.
https://doi.org/10.1182/blood-2025-910
Published: 2025